very few Aussie's know about the products - wait for mass adoption across our population - I don't see why revenue from Aus alone won't get to $20-$30m pa in the short to medium term (currently $8-$10m pa off a very low number of consumers)
the fact that their wide range of products are clinically proven with no direct competition whatsoever is extremely exciting & should make shareholders proud!
disclaimer I own shares in ASX BIO
do not rely on anything I say
do your own homework & research
Ann: Investor webinar and investor hub, page-20
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.060(11.5%) |
Mkt cap ! $124.7M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 58.5¢ | 53.0¢ | $1.045M | 1.858M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2260 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 4539 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BIO (ASX) Chart |